Dipartimento Emergenza, Presidio Ospedaliero Morgagni-Pierantoni, Azienda USL della Romagna, Via C Forlanini 34, 47121, Forlì, FC, Italy.
Dipartimento Cardio-vascolare, Presidio Ospedaliero Morgagni-Pierantoni, AUSL della Romagna, Via C Forlanini 34, 47121, Forlì, FC, Italy.
Intern Emerg Med. 2019 Apr;14(3):403-410. doi: 10.1007/s11739-018-1996-6. Epub 2018 Nov 29.
The reliability of initial high-sensitivity cardiac troponin T (hs-cTnT) under limit-of-detection in ruling-out short- and long-term acute coronary events in subjects for suspected non-ST-segment elevation acute coronary syndrome (NSTE-ACS) is not definitely settled. In a retrospective chart review analysis, 1001 subjects with hs-cTnT ≤ 14 ng/L out of 4053 subjects with hs-cTnT measured at Emergency Department (ED) presentation were recruited. The main outcome measure is fatal or non-fatal myocardial infarction (MI) within 30 days; secondary outcomes are MI or major acute coronary events (MACE) as a combination of MI or re-hospitalization for unstable angina within 1 year. In subjects with hs-cTnT < 5 ng/L [32.6% of cases, mean age 63 years (interquartile range 23)], no cases (0%, NPV 100%) had MI within 30 days, 2 cases (0.6%, NPV 99.4%) MI at 1-year, and 11 cases (3.4%, NPV 96.6%) MACE at 1-year. Patients with hs-cTnT < 5 ng/L would have benefited from a shortened decision (9.30 h and 53% overnight ED stay saved). Hs-cTnT < 5 ng/L is confirmed as safe for patients and comfortable for physicians in ruling out MI or MACE both at short and long term, suggesting that a sizable number of patients can be rapidly discharged without unnecessary diagnostic tests and ED observation.
在疑似非 ST 段抬高型急性冠状动脉综合征(NSTE-ACS)患者中,检测下限以下的初始高敏心肌肌钙蛋白 T(hs-cTnT)的可靠性是否能排除短期和长期急性冠状动脉事件尚未明确。在一项回顾性图表审查分析中,共纳入了 4053 例在急诊就诊时检测 hs-cTnT 的患者中,hs-cTnT≤14ng/L 的 1001 例患者。主要观察终点是 30 天内的致死性或非致死性心肌梗死(MI);次要观察终点是 MI 或主要急性冠状动脉事件(MACE),包括 MI 或不稳定型心绞痛再住院。在 hs-cTnT<5ng/L 的患者(占病例的 32.6%,平均年龄 63 岁(四分位间距 23))中,30 天内无 MI 病例(0%,NPV 为 100%),1 年内有 2 例 MI(0.6%,NPV 为 99.4%),1 年内有 11 例 MACE(3.4%,NPV 为 96.6%)。hs-cTnT<5ng/L 的患者可以缩短决策时间(节省 9.30 小时,节省 53%的夜间急诊留观时间)。hs-cTnT<5ng/L 可安全排除 MI 或 MACE,无论是短期还是长期,对患者和医生都舒适,这表明相当数量的患者可以在无需不必要的诊断检查和急诊观察的情况下快速出院。